First ESMO - Eur. Oncology Virtual Journal Club on May 22 at 630pm (CEST) - pencil down your agendas! Important data to be discussed by experts George Pentheroudakis FabriceAndre Solange Peters Andres Cervantes
esmo.org/about-esmo-mee…

Congratulations Dr. Steven Rosenberg Surgery Branch National Cancer Institute for the #AACR24 AACR Award for Lifetime Achievement in Cancer Research 🏆!

🧪 All you need to know about the state of play of cell therapy in solid cancers - Fantastic tour de force talk by Sebastian Klobuch AACR #AACR24 on advances in TILs & modified-TCR therapies.

Also check out the latest review by Sebastian Klobuch & colleagues The Netherlands Cancer Institute 👇
nature.com/articles/s4157…

Are you attending AACR #AACR24 on in San Diego 🇺🇸 this week?

Our Special Issue ‘Developments in Cell Therapy’ Editor - Sebastian Klobuch is here!

Looking forward to discussing your work.

Are you attending Keystone Symposia #KSCheckpoint24 on #CancerImmunotherapy in Whistler 🇨🇦 this week?

Our Special Issue ‘Developments in Cell Therapy’ Editor - Alena Gros is here!

Looking forward to discussing your work.

🚨 SPECIAL ISSUE: Developments in Cell Therapy 🚨

⏰ Submit an original article/review by 1 July 2024

📈 2022 CiteScore: 5.5

🔖 Indexed on PMC & PubMed National Library of Medicine: 'Immunooncol Technol'

Further details: spkl.io/60164sUYj
Guest editors: Alena Gros & Sebastian Klobuch

A masterclass in immune related adverse events from Lavinia Spain ESMO IOTECH

🔬Latest from Lavinia Spain and colleagues

Updates in the pathogenesis and management of irAEs: enterocolitis, hepatitis and cardiovascular toxicities

Available #OpenAccess 👇
esmoiotech.org/article/S2590-…

✨SPECIAL ISSUE: Immunoengineering for cancer✨

🔖Latest REVIEW now in print by Cui, Zhang Aarhus University & Yang Shi Uniklinik RWTH AC RWTH Aachen:
Biomaterials-mediated ligation of immune cell surface receptors for immunoengineering

Available #OpenAccess 👇 esmoiotech.org/article/S2590-…

IOTECH invites submissions for our Special Issue on Developments in Cell Therapy. Submission deadline: 8 March 2024. Find out more and submit your manuscript ➡️ spkl.io/60164sUYa ESMO IOTECH

The new EiCs of the ESMO Journals officially started their mandates this month. We look forward to witnessing the continued growth of the ESMO Journals under their guidance.

👏 Tom Powles G Curigliano MD PhD Rodrigo Dienstmann_MD_MBA Florian Lordick Prof. Irit Ben-Aharon John Haanen

👉ow.ly/k3kZ50Qusm5

🚨 SPECIAL ISSUE: Developments in Cell Therapy 🚨

⏰ There's still time to consider submitting an original article or review - deadline 8 March 2024.

📈 ESMO IOTECH 2022 CiteScore: 5.5

Further details: spkl.io/60164sUYj
Guest editors: Alena Gros & Sebastian Klobuch

📢Check out this latest original article Caroline Nunes-Xavier & colleagues IIS Biobizkaia Oslounivsykehus NanoString Universidad Europea

🔬Distinct spatial landscapes in clear-cell renal cell carcinoma as revealed by whole transcriptome

Available #OpenAccess 👇
esmoiotech.org/article/S2590-…

✨SPECIAL ISSUE: Immunoengineering for cancer✨

🔖Latest REVIEW now in print from Prabhani Atukorale & colleagues UMass Biomedical Engineering:
'Engineering approaches for innate immune-mediated tumor microenvironment remodeling'

Available #OpenAccess 👇
esmoiotech.org/article/S2590-…

We are inviting submissions for our Special Issue on Developments in Cell Therapy ESMO IOTECH . Submission deadline: 8 March 2024. Find out more and submit your manuscript ➡️ spkl.io/60154sUYl
ESMO IOTECH

Results of the joint international ESMO - Eur. Oncology and EBMT_Cellular_Therapy survey on current strategies of cell and gene therapy for solid tumors are reported in a Letter to the Editor in Annals of Oncology 👇
annalsofoncology.org/article/S0923-…
Annalisa Ruggeri Jurgen Kuball John Haanen George Pentheroudakis

📚 The book of ABSTRACTS from last month's #ESMOImmuno23 is now officially published!

Check out the latest research on:
▶️ Biomarkers
▶️ Cell therapy
▶️ Clinical practice
▶️ Therapeutic development
▶️ Tumour biology & TME

Available #OpenAccess 👇
esmoiotech.org/issue/S2590-01…

🔖 Latest REVIEW by Johanna & colleagues UMC Utrecht International The Netherlands Cancer Institute Radboud University @[email protected] University of Groningen

🏥🧪 Basics of ATMP development in academic pharma & the role of a GMP simulation unit
#cellulartherapy

Available #OpenAccess 👇
esmoiotech.org/article/S2590-…

✨SPECIAL ISSUE: Immunoengineering for cancer ✨

Now in print from Bao Lab Purdue Chemical Engineering:
'Generation of chimeric antigen receptor macrophages from human pluripotent stem cells to target glioblastoma'

Available #OpenAccess 👇 esmoiotech.org/article/S2590-…

IOTECH invites submissions for our Special Issue on Developments in Cell Therapy. Submission deadline: 8 March 2024. Find out more and submit your manuscript ➡️ spkl.io/60154sUYl ESMO IOTECH